China Has Spent Over $18.8 Billion on COVID-19 Vaccines

Another Chinese-made COVID-19 vaccine by Sinovac is already in use. It has not been approved. The approval code on its package shows “TBA.” December 2020. The Epoch Times

The National Healthcare Security Administration of the Chinese Communist Party recently announced that the total cost of China’s COVID-19 virus (CCP virus) vaccine has reached more than 120 billion yuan (about $18.8 billion). The recent financial reports disclosed by Chinese COVID-19 vaccine manufacturers show that they have made a lot of money.

Chinese authorities stated a few days ago that as of March 31, 2022, China had administered a total of 3.27 billion doses of the COVID-19 vaccines, at a cost of more than 120 billion yuan (about $18.8 billion). The total number of people vaccinated reached 1.278 billion, covering 90.63 percent of the country’s population.